These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16515323)

  • 1. [Olmesartan: antihypertensive therapy].
    Krankenpfl J; 2005; 43(7-10):254. PubMed ID: 16515323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modern hypertension treatment. More than effective blood pressure reduction].
    MMW Fortschr Med; 2012 Nov; 154(20):78-9. PubMed ID: 23234126
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Vivencio B
    Curr Med Res Opin; 2009 Sep; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488
    [No Abstract]   [Full Text] [Related]  

  • 4. ["High dosage monotherapy"].
    Schmieder RE
    Krankenpfl J; 2005; 43(1-3):63. PubMed ID: 15912851
    [No Abstract]   [Full Text] [Related]  

  • 5. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fast to the blood pressure goal. Lengthy dose adjustments harm compliance].
    MMW Fortschr Med; 2003 Sep; 145(39):53. PubMed ID: 14649079
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of olmesartan medoxomil alone and in combination with hydrochlorothiazide.
    Punzi HA
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):229-39. PubMed ID: 19296759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963998
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension: improved therapy adherence after switch to a fixed drug combinations].
    MMW Fortschr Med; 2012 Mar; 154(5):78-9. PubMed ID: 22624273
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.
    Parati G; Ochoa JE; Ramos C; Hoshide S; Lonati L; Bilo G
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):301-13. PubMed ID: 20921092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview.
    Brunner HR
    J Hum Hypertens; 2002 May; 16 Suppl 2():S13-6. PubMed ID: 11967728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Olmesartan-associated Sprue-like Enteropathy.
    Nagashima K; Katsurada T; Sakamoto N
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):A45-A46. PubMed ID: 29247793
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
    Chrysant SG; Weber MA; Wang AC; Hinman DJ
    Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy.
    Tocci G; Volpe M
    Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):829-40. PubMed ID: 21809963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S; Lee J; Karki S; Melino M
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs.
    Stumpe KO; Ludwig M
    J Hum Hypertens; 2002 May; 16 Suppl 2():S24-8. PubMed ID: 11967729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertension.
    Punzi HA; Lewin A; Li W; Chavanu KJ
    Adv Ther; 2012 Jun; 29(6):524-37. PubMed ID: 22763801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM; Heagerty A; Laeis P
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.